Trademark: 87236919
Status Date
Tuesday, June 18, 2019
Registration Number
5782112
Registration Date
Tuesday, June 18, 2019
Filing Date
Tuesday, November 15, 2016
Published for Opposition
Tuesday, August 29, 2017
35 Market analysis services in the field of specialty drug commercialization; Business consulting services relating to product distribution and operations management in the field of new specialty drugs; Patient relationship management services; Business consulting services relating to the operation of quick start and interim care programs; Management services provided to pharmaceutical manufacturers for controlling drug inventories; Healthcare business administration services, namely, administering patient reimbursement programs and administering pharmacy reimbursement programs; Business management in the field of patient assistance programs, prescription drugs and new specialty drugs
36 Claims administration services in the field of health insurance, namely, administration and coordination of healthcare assignment of benefits for others and verification of patient eligibility for health- and prescription-benefits coverage of pharmaceuticals; Financial administration of patient reimbursement programs; Financial management of reimbursement payments for others
41 Educational services, namely, conducting programs in the fields of drug therapy, side effect management, lifestyle management, disease state management and proper administration of medication; Educational services, namely, providing clinical support programs regarding drug therapy, side effect management, disease state management and proper administration of medication
42 Data warehousing services; Database development services, namely, collecting and maintaining patient information and registry data; Database development services, namely, customized data collection and maintaining related databases in the field of prescription drugs; Software as a service (SAAS) services, namely, hosting software for use by others for the purpose of connecting clinical programs with specialty drug manufacturers, and managing inventory, billing and account receivables, as well as shipping and reporting, master patient data aggregation and analysis, and call center services; Developing customized software for others for the purpose of connecting clinical programs with specialty drug manufacturers, and managing inventory, billing and account receivables, as well as managing shipping and reporting, master patient data aggregation and analysis, and call center services
44 Medical counseling in the field of drug therapy, side effect management, disease state management and proper administration of medication; Pharmaceutical consultation in the field of new specialty drugs; Providing information to patients in the field of administering medications; Providing medical information to patients; Patient health care counseling and advice regarding products in the field of prescription drugs; Providing information in the field of prescription drugs distributed via the Internet
45 Personal lifestyle consulting services; Providing patient advocate and case management services, namely, coordinating the procurement and administration of medication; Providing emotional counseling and emotional support services for medical patients
Jun 18, 2019
Registered-Principal Register
May 14, 2019
Notice Of Acceptance Of Statement Of Use E-Mailed
May 13, 2019
Allowed Principal Register - Sou Accepted
Apr 30, 2019
Notice Of Approval Of Extension Request E-Mailed
Apr 29, 2019
Statement Of Use Processing Complete
Apr 23, 2019
Use Amendment Filed
Apr 29, 2019
Extension 3 Granted
Apr 23, 2019
Extension 3 Filed
Apr 29, 2019
Case Assigned To Intent To Use Paralegal
Apr 23, 2019
Teas Extension Received
Apr 23, 2019
Teas Statement Of Use Received
Oct 25, 2018
Notice Of Approval Of Extension Request E-Mailed
Oct 23, 2018
Extension 2 Granted
Oct 23, 2018
Extension 2 Filed
Oct 23, 2018
Teas Extension Received
Apr 26, 2018
Notice Of Approval Of Extension Request E-Mailed
Apr 24, 2018
Extension 1 Granted
Apr 24, 2018
Extension 1 Filed
Apr 24, 2018
Teas Extension Received
Oct 24, 2017
Noa E-Mailed - Sou Required From Applicant
Aug 29, 2017
Official Gazette Publication Confirmation E-Mailed
Aug 29, 2017
Published For Opposition
Aug 9, 2017
Notification Of Notice Of Publication E-Mailed
Jul 21, 2017
Approved For Pub - Principal Register
Jul 21, 2017
Examiner's Amendment Entered
Jul 21, 2017
Notification Of Examiners Amendment E-Mailed
Jul 21, 2017
Examiners Amendment E-Mailed
Jul 21, 2017
Examiners Amendment -Written
Jul 5, 2017
Notification Of Final Refusal Emailed
Jul 5, 2017
Final Refusal E-Mailed
Jul 5, 2017
Final Refusal Written
Jun 16, 2017
Teas/Email Correspondence Entered
Jun 15, 2017
Correspondence Received In Law Office
Jun 15, 2017
Teas Response To Office Action Received
Jun 16, 2017
Teas Voluntary Amendment Received
May 12, 2017
Attorney/Dom.Rep.Revoked And/Or Appointed
May 12, 2017
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Feb 22, 2017
Notification Of Non-Final Action E-Mailed
Feb 22, 2017
Non-Final Action E-Mailed
Feb 22, 2017
Non-Final Action Written
Feb 22, 2017
Assigned To Examiner
Nov 22, 2016
Notice Of Pseudo Mark E-Mailed
Nov 21, 2016
New Application Office Supplied Data Entered In Tram
Nov 18, 2016
New Application Entered In Tram
Trademark Alertz updated from USPTO on 2030-01-24
